Submit your abstract for ICOM education day at the #NASBS Annual Meeting by Dec 1! We invite submissions from professionals in the #SkullBase & #neurosurgical communities to share innovative research, clinical experience, or technical advancements. bit.ly/43YyJ7V

Join us next week for the #ICOM #Meningioma Meeting at SNO in Honolulu! At this meeting, we will be presenting cutting edge meningioma research and an opportunity to establish new collaborations and expand and advance ICOM. All are welcome.

Our #ICOM member Dr. Duong Trung Kien attending the ASEAN Neurosurgical Conference in Indonesia last month.

RTOG Foundation recently opened a new trial RTOG 3523, also known as the “MOMENTUM-1” study, testing the radioactive drug [177Lu]Lu-DOTA-TATE in adult who have progressive intracranial grade 1-3 #meningioma. Read about the exciting new trial here: bit.ly/3LKevZd

Join us at the SNO meetings in Honolulu on November 21st for the #ICOM #Meningioma Meeting! We will be presenting cutting edge meningioma research and an opportunity to establish new collaborations and expand and advance ICOM. All are welcome.

🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference! #EANO #BrainTumourAwareness #btsm #BrainTumours

“Long-Term Outcomes of Active Surveillance After DOTATATE PET/MRI–Confirmed Gross Total Resection in WHO Grade 2 #Meningioma” is now available in NOA as an accepted manuscript: academic.oup.com/noa/advance-...

Our #ICOM member Dr. Duong Trung Kien, Head Department of Neurosurgery at Saint Paul Hospital in Hanoi, Vietnam, at #CNS 2025!

Read the oral abstract poster from August aiming to identify chromosomal copy number alterations which could be used to improve the current CNS WHO grading of meningioma. Read more in @EditorNeuro: bit.ly/4ng5d4m

Read the letter to the editor ‘PAS+/PASD- intracytoplasmic glycogen is not specific for clear cell #meningioma’ published in the Journal of #Neuropathology & Experimental #Neurology: bit.ly/4986hUr

Read about the first study to comprehensively define the molecular landscape of #meningiomas treated with #Radiotherapy in a prospective clinical trial in #NeuroOncology Advances: bit.ly/4okYUNK

This recent article found that #mesothelin is a viable CAR T-cell target for #meningiomas, and mesothelin-specific CAR T-cell therapy shows strong preclinical efficacy. Read more in #NeuroOncology: bit.ly/43bm94Q

Read the poster presentation in #NeuroOncology around a new study showing that preoperative #PET imaging may significantly adjust and extend resection boundaries in #meningiomas, particularly in cases of skull base and #IntraosseousMeningiomas. bit.ly/3IIgVqr

An older but insightful article by some #ICOM members, highlighting diagnostic challenges of #meningiomas from the #neuroimaging and #neuropathological side, presenting scientific achievements & studies potentially helping in overcoming these challenges: academic.oup.com/neuro-oncolo...

“Understanding the role of the Hippo signalling pathway in ependymoma tumour biology” is available in the first volume of the new #NeuroOncology #Pediatrics: bit.ly/471UhkK

Read the systematic review and meta-analysis which evaluates the effect of #GammaKnife #radiosurgery dose-rate on managing intracranial targets, encompassing an assessment of its association with radiation-related toxicity and adverse effects. bit.ly/3Kt8UWJ

A new article in @BrainTumourOrg highlights the findings from the Lancet Oncology paper ‘Analysis of TERT association with clinical outcome in #meningiomas: a multi-institutional cohort study’ bit.ly/46CpXhN

Meet #ICOM member Clara Lopez, a biologist and PhD student driven by a passion for #CancerResearch. From Spain to New Zealand’s Gillies McIndoe Research Institute, she explores #meningiomas to unlock new drug treatments. Outside the lab, she loves playing frisbee with friends.

This new study highlights the role of #NOTCH3 in mediating fatty acid oxidation in #meningiomas, and a potential mechanism for increased malignant potential of NOTCH3 + meningiomas. bit.ly/42dfxTc

What are the correlations between surface marker patterns in #meningiomas, prognosis, and location? Read more about this recent research in the Journal of Clinical Neuroscience: bit.ly/4mAcTOD

Findings: 🧠Response #biomarkers are needed for successful #NeuroOncology #immunotherapy trials 🧠Multiple molecular, cellular & radiologic approaches have shown promise 🧠Validation is needed before these biomarkers can be used to inform clinical trials bit.ly/3Iyxox6

This study provides regional insight into the molecular landscape of #meningiomas. It found while routine molecular profiling adds value to classification and prognostication, broader implementation may be limited by cost and panel coverage constraints. bit.ly/3Iuq71e

Read the new review in #NeuroOncology Advances focusing on recent advances and highlighting the #epidemiological, #pathological, #molecular/genetic, and clinical characteristics of #SpinalMeningiomas. academic.oup.com/noa/article/...

In our new special edition, #Immunotherapy for #BrainTumors, Alexander P Landry, Gavin P Dunn, and Michael Lim provide an overview of the current state of neuro-oncologic immunotherapy as covered in the supplement. academic.oup.com/noa/article/...

This new review and analysis reveals that #meningiomas can significantly impact #CognitiveFunction, affecting various domains such as memory, executive function, attention, and language. Most of these domains seem to improve postoperatively. bit.ly/4nn0RJb

The new supplement on #Immunotherapy for #BrainTumors is now out in #NeuroOncologyAdvances, edited by Alex Landry, Michael Lim, and Gavin Dunn. Thank you to the authors, peer reviewers, manuscript editors, and Editor-In-Chief @gelarehzadeh.bsky.social. bit.ly/460ahEQ

New Genetic Biomarker Flags Aggressive Brain Tumors @gelarehzadeh.bsky.social @mayocliniccancer.bsky.social @thelancetoncol.bsky.social #btsm #oncology www.onclive.com/view/new-gen...

Dr Linda Bi, Dr Ruchit Patel, Dr Chloe Gui, Dr Farshad Nassiri, and Dr Matija Snuderl joined the #Lancet #Oncology “In Conversation with” #podcast to discuss their new papers on #TERTexpression and TERT promoter mutations in #meningiomas. Listen now: www.thelancet.com/multimedia/p...

#ICOM & some of our members just published an article investigating the prevalence & prognostic association of #TERT expression in #meningiomas, with implications for diagnosis & treatment: bit.ly/4g8L0LZ @gelarehzadeh.bsky.social @justinzwang.bsky.social @felixehretmd.bsky.social @syip.bsky.social

What is the potential for #MolecularProfiling to refine surgical and #radiotherapy decision-making in #meningioma? Read the recent study in @NatureMedicine: go.nature.com/3GygVIj

#BAP1-altered #meningiomas represent a distinct and aggressive CNS tumor subtype associated with PRC dysregulation and recurrent 3p chromosome loss. These findings support the designation “meningioma, BAP1-altered.” Read full article in #NeuroOncology: bit.ly/3YWa1CN

Do you have clinical and research interests in #meningiomas, and want to find out more about becoming an #ICOM member? Contact us today: bit.ly/3HyhPoD

Collision tumors are rare. Among these, the metastasis of #melanoma into an intracranial #meningioma is particularly uncommon, with only 4 previously reported cases. This #CaseReport present the 5th documented case. bit.ly/3HOyZyr

This new study in Scientific Reports evaluates intracranial pressure in NF2-associated #meningiomas using perioperative #OpticNerveSheath diameter measurements. Read it now: go.nature.com/4oJWSI7

Have you read the new edition of our #ICOM newsletter? In it, you can read about the latest #meningioma-related events and articles from our members. adobe.ly/45yJe1R

Read this recent study in the JNS exploring potential correlations between the recurrence rate of #SphenoOrbital #meningiomas and the extent of resection of both the bony tumor portion and soft tumor portion. bit.ly/4mkxNBL

Read the new article “Postoperative #radiotherapy in subtotally resected recurrent WHO grade 1 #meningiomas with intermediate-/high-risk molecular profiles” in #NeuroOncology by authors including our #ICOM members: bit.ly/40wecpJ

The new edition of our #ICOM newsletter is now out! Read about the latest #meningioma-related events and articles from our members: adobe.ly/45yJe1R

A new study, showing that unidimensional tumor measurements and tumor volume assessments show a stronger association with overall survival than bidimensional measurements in recurrent non-benign #meningiomas, is now out in #NeuroOncology Advances: bit.ly/4l0xrPx

Read the Molecular Tumor Board Case Report in #NeuroOncologyAdvances on ‘Somatic SMARCB1 mutation in #SpinalMeningioma represents branched evolution in a patient with multiple sporadic #meningiomas’ now: bit.ly/41fTPx9

Our organization is truly #global, with #members from across Canada, the USA, Italy, Germany, the UK, Australia, Denmark, Hong Kong, Ireland, and Brazil. To learn more about #membership, click here: bit.ly/44xM7kG

Photos from the 2025 #BrainTumor Epidemiology Consortium (#BTEC) meeting at Duke University, including and Invited Speaker Panel of Quinn Ostrom, PhD (Duke); Priya Kumthekar, MD (Northwestern); Priscilla Brastianos, MD (Harvard); and John de Groot, MD (UCSF).

#ICOM was featured in the Mayo Clinic’s new article: “Launched in 2016, ICOM has 52 institutions working together to better understand treatment options, #meningioma biology that can guide management, and the most up-to-date indications for treatment.” www.mayoclinic.org/medical-prof...

#Meningiomas comprise 40% of all CNS neoplasms, with peak prevalence occurring in the 5th & 6th decades of life. Presenting symptoms vary between patients and are location-dependent, but new-onset seizures bring a subset of patients to clinical attention. bit.ly/46pC02j

Clara Lopez recently presented her research findings on "Exploring the Hormonal Influence and Sex-Specific Effects of Drug Metabolism in #Meningothelial and #AtypicalMeningioma” at the Department of Anaesthesia and Surgery's Biomedical Seminar Series in Wellington, New Zealand.

“Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas” is now out in @eBioMedicine! Read full article here: bit.ly/4lE6G47

What are some topics of interest for us at #ICOM? These include (but are not limited to): - Current standard of #ClinicalCare - #Epidemiology - Quality of life and survivorship - #ClinicalTrial design - Molecular characterization Learn more here: buff.ly/4tsOyaG

This study, using retrospective data on 2,824 #meningiomas, highlights the potential for #MolecularProfiling to refine #surgical and #radiotherapy decision-making. Read more: go.nature.com/3GygVIj

Bruno Miguel Fernandes de Carvalho, MD PhD is a #Neurosurgery Graduate Hospital Assistant at the Neurosurgery Dept of Centro Hospitalar Universitário São João, Portugal. He specializes in #NeurosurgicalOncology, specifically glioma, metastasis, #meningioma & schwannoma surgery.

This research from a few years ago demonstrated that global patterns of DNA methylation may be informative for the selection of #chemotherapies against #meningiomas, and existing drugs may enhance radiation sensitivity in high-risk cases. Read now: bit.ly/4lGLL0l